♥

Gufic Biosciences Limited

ISIN : INE742B01025
NSE : GUFICBIO
BSE : 509079
Face Value : 1
Industry : Pharmaceuticals & Drugs

EPS : 8.74
EPS (TTM) : 8.70
Price to Earning (P/E) : 38.48
Book Value : 53.11
Price to Bookvalue (P/B) : 6.33
Dividend Yield : 0 %
Return on Equity (ROE) : 16.17 %
Return on Capital Employed (ROCE) : 15.42 %

Gufic Biosciences share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	283 - 289.75 2.4 %
Low / High	278.95 - 290.55 4.2 %
Trade Volume	817
52 Week Low / High	267.5 - 409 52.9 %

YOU MAY ALSO LIKE

Stock market course tutorial
Stock Market Investment Course explained in simple words.
Share Market basics for beginners
Share Market jargons in simple terms
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR GUFIC BIOSCIENCES LIMITED

Date End	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	months	months	months	months	months	months
Net Sales	2148.74	2017.78	1949.94	2028.12
Total Income	2152.08	2022.02	1958.75	2040.67
Total Expenditure	1755.04	1653.23	1607.66	1670.33
Other Income	3.34	4.24	8.81	12.55
Operating Profit	397.04	368.79	351.09	370.34
Interest	44.61	31.79	36.47	46.24
PBDT	352.43	337	314.62	324.1
Depreciation	42.97	41.42	43.42	43.05
Profit Before Tax	309.46	295.58	271.2	281.05
Tax	77.36	73.01	70.73	72.49
Profit After Tax	232.1	222.57	200.47	208.56
Net Profit	232.1	222.57	200.47	208.56
Equity Capital	96.94	100.28	100.28	100.28
Face Value (IN RS)	1	1	1	1
Calculated EPS	2.39	2.22	2	2.08
Diluted Eps After Extraordinary Items	2.39	2.23	2	2.08
Diluted Eps Before Extraordinary Items	2.39	2.23	2	2.08

STANDALONE QUARTERLY RESULT FOR GUFIC BIOSCIENCES LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1621.93	1652.76	1748.35	1774.73	1730.36	1950.2	2148.74	2017.78	1949.94	2028.12
Total Income	1622.34	1656.51	1756.54	1782.31	1736.59	1959.01	2152.08	2022.02	1958.75	2040.67
Total Expenditure	1306.73	1320.97	1422.23	1440.82	1408.87	1595.42	1755.04	1653.23	1607.66	1670.3
Other Income	0.41	3.75	8.18	7.57	6.23	8.81	3.34	4.24	8.81	12.55
Operating Profit	315.61	335.54	334.31	341.49	327.72	363.59	397.04	368.79	351.09	370.37
Interest	10.57	9.08	16.06	21.6	29.22	40.73	44.61	31.79	36.47	46.24
PBDT	305.04	326.46	318.25	319.89	298.5	322.86	352.43	337	314.62	324.13
Depreciation	43.27	43.65	45.64	47.41	59.18	42.36	42.97	41.42	43.42	43.05
Profit Before Tax	261.77	282.81	272.61	272.48	239.32	280.5	309.46	295.58	271.2	281.08
Tax	59.12	72.29	70.49	69.12	58.27	74.26	77.36	73.01	70.73	72.49
Profit After Tax	202.65	210.52	202.12	203.36	181.05	206.24	232.1	222.57	200.47	208.59
Net Profit	202.65	210.52	202.12	203.36	181.05	206.24	232.1	222.57	200.47	208.59
Equity Capital	96.94	96.94	96.94	96.95	96.94	96.94	96.94	100.28	100.28	100.28
Face Value (IN RS)	1	1	1	1	1	1	1	1	1	1
Calculated EPS	2.09	2.17	2.09	2.1	1.87	2.13	2.39	2.22	2	2.08
Diluted Eps After Extraordinary Items	2.09	2.17	2.09	2.1	1.87	2.13	2.39	2.23	2	2.08
Diluted Eps Before Extraordinary Items	2.09	2.17	2.09	2.1	1.87	2.13	2.39	2.23	2	2.08

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR GUFIC BIOSCIENCES LIMITED

Date End	Mar 2024
No of months	12 months	months	months
Net Sales	8066.66
Total Income	8088.43
Total Expenditure	6607.95
Other Income	21.77
Operating Profit	1480.48
Interest	153.6
PBDT	1326.88
Depreciation	170.17
Profit Before Tax	1156.71
Tax	295.36
Profit After Tax	861.35
Net Profit	861.35
Equity Capital	100.28
Face Value (IN RS)	1
Calculated EPS	8.59
Diluted Eps After Extraordinary Items	8.74
Diluted Eps Before Extraordinary Items	8.74

STANDALONE ANNUAL RESULT FOR GUFIC BIOSCIENCES LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	7791.56	6906.21	8066.66
Total Income	7822.6	6931.95	8088.43
Total Expenditure	6334.4	5559.7	6607.95
Other Income	31.04	25.74	21.77
Operating Profit	1488.2	1372.25	1480.48
Interest	48.47	82.23	153.6
PBDT	1439.73	1290.02	1326.88
Depreciation	171.34	222.81	170.17
Profit Before Tax	1268.39	1067.21	1156.71
Tax	309.98	270.16	295.36
Profit After Tax	958.41	797.05	861.35
Net Profit	958.41	797.05	861.35
Equity Capital	96.94	96.94	100.28
Face Value (IN RS)	1	1	1
Reserves	2594.24	3381.14	5225.33
Calculated EPS	9.89	8.22	8.59
Diluted Eps After Extraordinary Items	9.89	8.22	8.74
Diluted Eps Before Extraordinary Items	9.89	8.22	8.74

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR GUFIC BIOSCIENCES LIMITED

YEAR	Mar 2024
No of Months	12 months	months	months	months
Gross Sales	940.16 Cr	0	0	0
Sales	903.15 Cr	0	0	0
Processing Charges / Service Income	8.51 Cr	0	0	0
Net Sales	806.67 Cr	0	0	0
Increase/Decrease in Stock	57.48 Lk	0	0	0
Raw Material Consumed	338.49 Cr	0	0	0
Opening Raw Materials	52.08 Cr	0	0	0
Purchases Raw Materials	287.13 Cr	0	0	0
Closing Raw Materials	58.78 Cr	0	0	0
Other Direct Purchases / Brought in cost	58.06 Cr	0	0	0
Power & Fuel Cost	17.79 Cr	0	0	0
Electricity & Power	17.79 Cr	0	0	0
Employee Cost	109.63 Cr	0	0	0
Salaries, Wages & Bonus	95.84 Cr	0	0	0
Contributions to EPF & Pension Funds	4.08 Cr	0	0	0
Workmen and Staff Welfare Expenses	7.42 Cr	0	0	0
Other Manufacturing Expenses	89.75 Cr	0	0	0
Processing Charges	10.3 Cr	0	0	0
Repairs and Maintenance	8.73 Cr	0	0	0
Packing Material Consumed	50.83 Cr	0	0	0
General and Administration Expenses	53.61 Cr	0	0	0
Rent , Rates & Taxes	1.71 Cr	0	0	0
Insurance	2.29 Cr	0	0	0
Printing and stationery	1.79 Cr	0	0	0
Professional and legal fees	14.79 Cr	0	0	0
Traveling and conveyance	31.49 Cr	0	0	0
Selling and Distribution Expenses	40.2 Cr	0	0	0
Advertisement & Sales Promotion	2.12 Cr	0	0	0
Sales Commissions & Incentives	24.83 Cr	0	0	0
Freight and Forwarding	13.25 Cr	0	0	0
Miscellaneous Expenses	10.75 Cr	0	0	0
Provision for doubtful debts	1.21 Cr	0	0	0
Loss on disposal of fixed assets(net)	2.3 Cr	0	0	0
Total Expenditure	660.79 Cr	0	0	0
Other Income	2.18 Cr	0	0	0
Interest Received	1.41 Cr	0	0	0
Dividend Received	4,000	0	0	0
Foreign Exchange Gains	49.66 Lk	0	0	0
Operating Profit	148.05 Cr	0	0	0
Interest	15.36 Cr	0	0	0
Interest on Term Loan	12.54 Cr	0	0	0
Bank Charges etc	79.62 Lk	0	0	0
PBDT	132.69 Cr	0	0	0
Depreciation	17.02 Cr	0	0	0
Profit Before Taxation & Exceptional Items	115.67 Cr	0	0	0
Profit Before Tax	115.67 Cr	0	0	0
Provision for Tax	29.54 Cr	0	0	0
Current Income Tax	28.4 Cr	0	0	0
Deferred Tax	3.17 Cr	0	0	0
Profit After Tax	86.14 Cr	0	0	0
Consolidated Net Profit	86.14 Cr	0	0	0
Profit Balance B/F	267.29 Cr	0	0	0
Appropriations	353.43 Cr	0	0	0
Other Appropriation	96.94 Lk	0	0	0
Equity Dividend %	10
Earnings Per Share	8.59
Adjusted EPS	8.59

STANDALONE PROFIT / LOSS FOR GUFIC BIOSCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	489.48 Cr	848.11 Cr	800.82 Cr	940.16 Cr
Sales	435.73 Cr	781.97 Cr	789.96 Cr	903.15 Cr
Processing Charges / Service Income	50.99 Cr	63.64 Cr	5.58 Cr	8.51 Cr
Net Sales	487.7 Cr	779.16 Cr	690.62 Cr	806.67 Cr
Increase/Decrease in Stock	14.29 Cr	-19.39 Cr	-33.39 Cr	57.48 Lk
Raw Material Consumed	211.83 Cr	387.88 Cr	328.85 Cr	338.49 Cr
Opening Raw Materials	47.58 Cr	31.21 Cr	23.38 Cr	52.08 Cr
Purchases Raw Materials	172.9 Cr	302.63 Cr	331.71 Cr	287.13 Cr
Closing Raw Materials	31.21 Cr	23.38 Cr	52.08 Cr	58.78 Cr
Other Direct Purchases / Brought in cost	22.55 Cr	77.42 Cr	25.84 Cr	58.06 Cr
Power & Fuel Cost	9.94 Cr	11 Cr	15.24 Cr	17.79 Cr
Electricity & Power	9.94 Cr	11 Cr	15.24 Cr	17.79 Cr
Employee Cost	66.22 Cr	85.61 Cr	86.73 Cr	109.63 Cr
Salaries, Wages & Bonus	56.14 Cr	73.76 Cr	77.76 Cr	95.84 Cr
Contributions to EPF & Pension Funds	2.86 Cr	3.41 Cr	3.91 Cr	4.08 Cr
Workmen and Staff Welfare Expenses	5.73 Cr	7.09 Cr	3.2 Cr	7.42 Cr
Other Manufacturing Expenses	46.74 Cr	82.14 Cr	72.21 Cr	89.75 Cr
Processing Charges	6.77 Cr	7.84 Cr	8.12 Cr	10.3 Cr
Repairs and Maintenance	6.22 Cr	8.73 Cr	7.47 Cr	8.73 Cr
Packing Material Consumed	24.18 Cr	43.48 Cr	36.36 Cr	50.83 Cr
General and Administration Expenses	23.69 Cr	38.12 Cr	44.7 Cr	53.61 Cr
Rent , Rates & Taxes	1.12 Cr	4.99 Cr	1.49 Cr	1.71 Cr
Insurance	1.18 Cr	1.76 Cr	1.83 Cr	2.29 Cr
Printing and stationery	1.98 Cr	2.65 Cr	2.46 Cr	1.79 Cr
Professional and legal fees	6.97 Cr	11.2 Cr	11.8 Cr	14.79 Cr
Traveling and conveyance	11.37 Cr	16.18 Cr	25.82 Cr	31.49 Cr
Selling and Distribution Expenses	17.87 Cr	28.38 Cr	31.74 Cr	40.2 Cr
Advertisement & Sales Promotion	1.86 Cr	3.34 Cr	5.96 Cr	2.12 Cr
Sales Commissions & Incentives	6.18 Cr	11.06 Cr	13.45 Cr	24.83 Cr
Freight and Forwarding	9.83 Cr	13.98 Cr	12.33 Cr	13.25 Cr
Miscellaneous Expenses	13.2 Cr	19.7 Cr	9.88 Cr	10.75 Cr
Provision for doubtful debts	10.1 Lk	1.4 Cr	0	1.21 Cr
Loss on disposal of fixed assets(net)	0	0	0	2.3 Cr
Loss on foreign exchange fluctuations	2.01 Lk	0	2.96 Cr	0
Total Expenditure	403.78 Cr	633.44 Cr	555.97 Cr	660.79 Cr
Other Income	3.73 Cr	3.1 Cr	2.57 Cr	2.18 Cr
Interest Received	1.45 Cr	1.88 Cr	1.41 Cr	1.41 Cr
Dividend Received	0	5,000	5,000	4,000
Profit on sale of Fixed Assets	3.74 Lk	6.84 Lk	3.02 Lk	0
Provision Written Back	4.28 Lk	4.79 Lk	0	0
Foreign Exchange Gains	1.45 Cr	69.34 Lk	0	49.66 Lk
Operating Profit	87.65 Cr	148.82 Cr	137.22 Cr	148.05 Cr
Interest	13.63 Cr	4.85 Cr	8.22 Cr	15.36 Cr
Interest on Term Loan	9.66 Cr	2.53 Cr	5.32 Cr	12.54 Cr
Bank Charges etc	1.87 Cr	1.36 Cr	1.59 Cr	79.62 Lk
PBDT	74.02 Cr	143.97 Cr	129 Cr	132.69 Cr
Depreciation	16.31 Cr	17.13 Cr	22.28 Cr	17.02 Cr
Profit Before Taxation & Exceptional Items	57.71 Cr	126.84 Cr	106.72 Cr	115.67 Cr
Profit Before Tax	57.71 Cr	126.84 Cr	106.72 Cr	115.67 Cr
Provision for Tax	13.48 Cr	31 Cr	27.02 Cr	29.54 Cr
Current Income Tax	17.2 Cr	32.15 Cr	28.21 Cr	28.4 Cr
Deferred Tax	2.01 Cr	-1.15 Cr	-1.19 Cr	3.17 Cr
Profit After Tax	44.23 Cr	95.84 Cr	79.7 Cr	86.14 Cr
Consolidated Net Profit	44.23 Cr	95.84 Cr	79.7 Cr	86.14 Cr
Adjustments to PAT	1,000	0	0	0
Profit Balance B/F	49.58 Cr	93.68 Cr	188.56 Cr	267.29 Cr
Appropriations	93.81 Cr	189.52 Cr	268.26 Cr	353.43 Cr
Other Appropriation	12.67 Lk	96.94 Lk	96.94 Lk	96.94 Lk
Equity Dividend %	10	10	10	10
Earnings Per Share	4.56	9.89	8.22	8.59
Adjusted EPS	4.56	9.89	8.22	8.59

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR GUFIC BIOSCIENCES LIMITED

Year End	Mar 2024
No of Months	12 months	months	months	months
Profit Before Tax	115.67 Cr	0	0	0
Adjustment	34.15 Cr	0	0	0
Changes In working Capital	-130.23 Cr	0	0	0
Cash Flow after changes in Working Capital	19.59 Cr	0	0	0
Cash Flow from Operating Activities	-7.46 Cr	0	0	0
Cash Flow from Investing Activities	-102.39 Cr	0	0	0
Cash Flow from Financing Activitie	82.38 Cr	0	0	0
Net Cash Inflow / Outflow	-27.46 Cr	0	0	0
Opening Cash & Cash Equivalents	28.6 Cr	0	0	0
Closing Cash & Cash Equivalent	1.14 Cr	0	0	0

STANDALONE CASH FLOW FOR GUFIC BIOSCIENCES LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	57.71 Cr	126.84 Cr	106.72 Cr	115.67 Cr
Adjustment	30.79 Cr	20.86 Cr	29.64 Cr	34.15 Cr
Changes In working Capital	9.97 Cr	-10.2 Cr	-135.25 Cr	-130.23 Cr
Cash Flow after changes in Working Capital	98.47 Cr	137.5 Cr	1.11 Cr	19.59 Cr
Cash Flow from Operating Activities	89.06 Cr	104.44 Cr	-26.59 Cr	-7.46 Cr
Cash Flow from Investing Activities	-8.51 Cr	-95.94 Cr	-190.73 Cr	-102.4 Cr
Cash Flow from Financing Activitie	-78.62 Cr	-3.1 Cr	234.31 Cr	82.38 Cr
Net Cash Inflow / Outflow	1.94 Cr	5.41 Cr	16.99 Cr	-27.48 Cr
Opening Cash & Cash Equivalents	4.26 Cr	6.2 Cr	11.61 Cr	28.6 Cr
Closing Cash & Cash Equivalent	6.2 Cr	11.61 Cr	28.6 Cr	1.13 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR GUFIC BIOSCIENCES LIMITED

YEAR	Mar 2024
Share Capital	10.03 Cr	0	0	0
Equity - Authorised	10.52 Cr	0	0	0
Equity - Issued	10.03 Cr	0	0	0
Equity Paid Up	10.03 Cr	0	0	0
Face Value	1
Total Reserves	522.53 Cr	0	0	0
Securities Premium	99.66 Cr	0	0	0
Capital Reserves	72.13 Cr	0	0	0
Profit & Loss Account Balance	352.46 Cr	0	0	0
General Reserves	1.35 Cr	0	0	0
Reserve excluding Revaluation Reserve	522.53 Cr	0	0	0
Shareholder's Funds	532.56 Cr	0	0	0
Secured Loans	153.96 Cr	0	0	0
Term Loans - Banks	174.62 Cr	0	0	0
Deferred Tax Assets / Liabilities	2.06 Cr	0	0	0
Deferred Tax Assets	4.93 Cr	0	0	0
Deferred Tax Liability	6.99 Cr	0	0	0
Other Long Term Liabilities	16.53 Cr	0	0	0
Long Term Provisions	15.38 Cr	0	0	0
Total Non-Current Liabilities	187.93 Cr	0	0	0
Trade Payables	166.27 Cr	0	0	0
Sundry Creditors	166.27 Cr	0	0	0
Other Current Liabilities	56.48 Cr	0	0	0
Advances received from customers	3.85 Cr	0	0	0
Interest Accrued But Not Due	42.52 Lk	0	0	0
Short Term Borrowings	142.02 Cr	0	0	0
Secured ST Loans repayable on Demands	142.02 Cr	0	0	0
Working Capital Loans- Sec	142.02 Cr	0	0	0
Short Term Provisions	7.28 Cr	0	0	0
Provision for Tax	2.55 Cr	0	0	0
Total Current Liabilities	372.05 Cr	0	0	0
Total Liabilities	1092.54 Cr	0	0	0
Gross Block	246.23 Cr	0	0	0
Less: Accumulated Depreciation	87.34 Cr	0	0	0
Net Block	158.89 Cr	0	0	0
Capital Work in Progress	307.06 Cr	0	0	0
Non Current Investments	1.78 Cr	0	0	0
Long Term Investment	1.78 Cr	0	0	0
Unquoted	1.78 Cr	0	0	0
Long Term Loans & Advances	23.12 Cr	0	0	0
Other Non Current Assets	1.21 Cr	0	0	0
Total Non-Current Assets	492.06 Cr	0	0	0
Unquoted	1.78 Cr	0	0	0
Inventories	200.48 Cr	0	0	0
Raw Materials	58.78 Cr	0	0	0
Work-in Progress	55.28 Cr	0	0	0
Finished Goods	32.54 Cr	0	0	0
Packing Materials	27.51 Cr	0	0	0
Sundry Debtors	329.94 Cr	0	0	0
Debtors more than Six months	15.8 Cr	0	0	0
Debtors Others	319.72 Cr	0	0	0
Cash and Bank	13.48 Cr	0	0	0
Cash in hand	54.16 Lk	0	0	0
Balances at Bank	12.94 Cr	0	0	0
Other Current Assets	3.75 Cr	0	0	0
Prepaid Expenses	86.14 Lk	0	0	0
Short Term Loans and Advances	52.83 Cr	0	0	0
Advances recoverable in cash or in kind	13.31 Cr	0	0	0
Total Current Assets	600.48 Cr	0	0	0
Net Current Assets (Including Current Investments)	228.43 Cr	0	0	0
Total Assets	1092.54 Cr	0	0	0
Contingent Liabilities	6.62 Cr	0	0	0
Total Debt	317.03 Cr	0	0	0
Book Value	53.11
Adjusted Book Value	53.11

STANDALONE BALANCE SHEET FOR GUFIC BIOSCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	9.69 Cr	9.69 Cr	9.69 Cr	10.03 Cr
Equity - Authorised	10.52 Cr	10.52 Cr	10.52 Cr	10.52 Cr
Equity - Issued	9.69 Cr	9.69 Cr	9.69 Cr	10.03 Cr
Equity Paid Up	9.69 Cr	9.69 Cr	9.69 Cr	10.03 Cr
Face Value	1	1	1	1
Total Reserves	163.74 Cr	259.42 Cr	338.11 Cr	522.53 Cr
Securities Premium	0	0	0	99.66 Cr
Capital Reserves	70.88 Cr	72.13 Cr	72.13 Cr	72.13 Cr
Profit & Loss Account Balance	93.68 Cr	188.56 Cr	267.29 Cr	352.46 Cr
General Reserves	1.35 Cr	1.35 Cr	1.35 Cr	1.35 Cr
Reserve excluding Revaluation Reserve	163.74 Cr	259.42 Cr	338.11 Cr	522.53 Cr
Shareholder's Funds	173.44 Cr	269.12 Cr	347.81 Cr	532.56 Cr
Secured Loans	35.43 Cr	47.4 Cr	190.68 Cr	153.96 Cr
Term Loans - Banks	32.82 Cr	49.7 Cr	195.02 Cr	174.62 Cr
Deferred Tax Assets / Liabilities	1.49 Cr	18.94 Lk	-96.64 Lk	2.06 Cr
Deferred Tax Assets	2.69 Cr	3.58 Cr	3.91 Cr	4.93 Cr
Deferred Tax Liability	4.18 Cr	3.77 Cr	2.95 Cr	6.99 Cr
Other Long Term Liabilities	7.82 Cr	5.33 Cr	21.17 Cr	16.53 Cr
Long Term Provisions	10.23 Cr	12.39 Cr	13.29 Cr	15.38 Cr
Total Non-Current Liabilities	54.96 Cr	65.3 Cr	224.18 Cr	187.93 Cr
Trade Payables	113.03 Cr	140.95 Cr	130.26 Cr	166.27 Cr
Sundry Creditors	113.03 Cr	140.95 Cr	130.26 Cr	166.27 Cr
Other Current Liabilities	28.16 Cr	33.89 Cr	38.82 Cr	56.48 Cr
Advances received from customers	2.83 Cr	6.03 Cr	0	3.85 Cr
Interest Accrued But Not Due	28.22 Lk	23.35 Lk	30.53 Lk	42.52 Lk
Short Term Borrowings	16.32 Cr	6.6 Cr	111.76 Cr	142.02 Cr
Secured ST Loans repayable on Demands	16.32 Cr	6.6 Cr	111.76 Cr	142.02 Cr
Working Capital Loans- Sec	16.32 Cr	6.6 Cr	111.76 Cr	142.02 Cr
Short Term Provisions	62.33 Cr	5.55 Cr	7.37 Cr	7.28 Cr
Provision for Tax	57.77 Cr	67.48 Lk	3.12 Cr	2.55 Cr
Total Current Liabilities	219.85 Cr	186.98 Cr	288.21 Cr	372.05 Cr
Total Liabilities	448.24 Cr	521.4 Cr	860.19 Cr	1092.54 Cr
Gross Block	148.64 Cr	177.85 Cr	246.31 Cr	246.23 Cr
Less: Accumulated Depreciation	48.67 Cr	62.69 Cr	86.74 Cr	87.34 Cr
Net Block	99.97 Cr	115.17 Cr	159.57 Cr	158.89 Cr
Capital Work in Progress	13.4 Cr	40.87 Cr	169.59 Cr	307.06 Cr
Non Current Investments	75,000	75,000	78.43 Lk	1.79 Cr
Long Term Investment	75,000	75,000	78.43 Lk	1.79 Cr
Unquoted	75,000	75,000	78.43 Lk	1.79 Cr
Long Term Loans & Advances	17.12 Cr	43.65 Cr	64.35 Cr	23.12 Cr
Other Non Current Assets	97.89 Lk	94.88 Lk	1.8 Cr	1.21 Cr
Total Non-Current Assets	131.48 Cr	200.65 Cr	396.08 Cr	492.07 Cr
Unquoted	75,000	75,000	78.43 Lk	1.79 Cr
Inventories	94.4 Cr	115.57 Cr	183.46 Cr	200.48 Cr
Raw Materials	31.21 Cr	23.38 Cr	52.08 Cr	58.78 Cr
Work-in Progress	28.23 Cr	20.45 Cr	57.39 Cr	55.28 Cr
Finished Goods	19.86 Cr	38.68 Cr	36.57 Cr	32.54 Cr
Packing Materials	10.98 Cr	20.83 Cr	25.85 Cr	27.51 Cr
Sundry Debtors	124.5 Cr	151.55 Cr	205.47 Cr	329.94 Cr
Debtors more than Six months	9.83 Cr	12.63 Cr	18.95 Cr	15.8 Cr
Debtors Others	117.7 Cr	143.36 Cr	190.89 Cr	319.72 Cr
Cash and Bank	13.18 Cr	26.57 Cr	46.69 Cr	13.47 Cr
Cash in hand	77.62 Lk	72,000	3.97 Lk	54.16 Lk
Balances at Bank	9.28 Cr	24.11 Cr	43.56 Cr	12.93 Cr
Other Current Assets	68.77 Lk	85.5 Lk	1.79 Cr	3.75 Cr
Prepaid Expenses	58.02 Lk	85.09 Lk	95.02 Lk	86.14 Lk
Short Term Loans and Advances	84 Cr	26.21 Cr	26.71 Cr	52.83 Cr
Advances recoverable in cash or in kind	10.22 Cr	8.73 Cr	8.17 Cr	13.31 Cr
Advance income tax and TDS	56.18 Cr	0	0	0
Total Current Assets	316.77 Cr	320.75 Cr	464.11 Cr	600.47 Cr
Net Current Assets (Including Current Investments)	96.92 Cr	133.77 Cr	175.9 Cr	228.42 Cr
Total Assets	448.24 Cr	521.4 Cr	860.19 Cr	1092.54 Cr
Contingent Liabilities	13.57 Cr	9.43 Cr	6.7 Cr	6.62 Cr
Total Debt	55.35 Cr	61.24 Cr	311.41 Cr	317.03 Cr
Book Value	17.89	27.76	35.88	53.11
Adjusted Book Value	17.89	27.76	35.88	53.11

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR GUFIC BIOSCIENCES LIMITED

YEAR	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	8.59
CEPS(Rs)	10.29
DPS(Rs)	0.1
Book NAV/Share(Rs)	53.11
Tax Rate(%)	25.53
Margin Ratios
Core EBITDA Margin(%)	15.52
EBIT Margin(%)	13.94
Pre Tax Margin(%)	12.3
PAT Margin (%)	9.16
Cash Profit Margin (%)	10.97
Performance Ratios
ROA(%)	7.88
ROE(%)	16.17
ROCE(%)	15.42
Asset Turnover(x)	0.86
Sales/Fixed Asset(x)	3.82
Working Capital/Sales(x)	4.12
Efficiency Ratios
Fixed Capital/Sales(x)	0.26
Receivable days	128.09
Inventory Days	77.83
Payable days	178.99
Valuation Parameters
PER(x)	32.96
PCE(x)	27.53
Price/Book(x)	5.33
Yield(%)	0.04
EV/Net Sales(x)	3.9
EV/Core EBITDA(x)	21.23
EV/EBIT(x)	23.99
EV/CE(x)	3.7
M Cap / Sales	3.52
Growth Ratio
Financial Stability Ratios
Total Debt/Equity(x)	0.6
Current Ratio(x)	1.61
Quick Ratio(x)	1.08
Interest Cover(x)	8.53
Total Debt/Mcap(x)	0.11

FINANCIAL RATIOS (STANDALONE) FOR GUFIC BIOSCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	4.56	9.89	8.22	8.59
CEPS(Rs)	6.24	11.65	10.52	10.29
DPS(Rs)	0.1	0.1	0.1	0.1
Book NAV/Share(Rs)	17.89	27.76	35.88	53.11
Tax Rate(%)	23.36	24.44	25.31	25.53
Margin Ratios
Core EBITDA Margin(%)	17.14	17.18	16.81	15.52
EBIT Margin(%)	14.58	15.53	14.35	13.94
Pre Tax Margin(%)	11.79	14.96	13.33	12.3
PAT Margin (%)	9.04	11.3	9.95	9.16
Cash Profit Margin (%)	12.37	13.32	12.74	10.97
Performance Ratios
ROA(%)	9.4	20.98	11.54	8.82
ROE(%)	29.22	43.31	25.84	19.57
ROCE(%)	30.05	47.1	23.23	17.37
Asset Turnover(x)	1.04	1.86	1.16	0.96
Sales/Fixed Asset(x)	3.71	5.2	3.76	3.82
Working Capital/Sales(x)	5.05	6.34	4.55	4.12
Efficiency Ratios
Fixed Capital/Sales(x)	0.27	0.19	0.27	0.26
Receivable days	86.3	59.4	81.36	103.93
Inventory Days	80.86	45.18	68.14	74.53
Payable days	111.92	124.89	167.52	159.61
Valuation Parameters
PER(x)	25.05	25.18	22.7	32.96
PCE(x)	18.3	21.36	17.74	27.53
Price/Book(x)	6.39	8.97	5.2	5.33
Yield(%)	0.09	0.04	0.05	0.04
EV/Net Sales(x)	2.36	3.14	3	3.9
EV/Core EBITDA(x)	13.12	16.45	15.12	21.23
EV/EBIT(x)	16.12	18.59	18.05	23.99
EV/CE(x)	2.57	4.69	2.41	3.7
M Cap / Sales	2.27	3.1	2.62	3.52
Growth Ratio
Net Sales Growth(%)	28.74	59.76	-11.36	16.8
Core EBITDA Growth(%)	51.37	69.78	-9.2	7.89
EBIT Growth(%)	62	84.58	-13.06	14
PAT Growth(%)	94.96	116.68	-16.84	8.07
EPS Growth(%)	94.95	116.68	-16.83	4.48
Financial Stability Ratios
Total Debt/Equity(x)	0.32	0.23	0.9	0.6
Current Ratio(x)	1.44	1.72	1.61	1.61
Quick Ratio(x)	1.01	1.1	0.97	1.08
Interest Cover(x)	5.23	27.17	13.98	8.53
Total Debt/Mcap(x)	0.06	0.03	0.17	0.11

SHARE HOLDING PATTERN FOR GUFIC BIOSCIENCES LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	75.00	75.00	75.00	75.00	75.00	75.00	72.51	72.51	72.50	72.51
FII %	1.38	0.06	0.16	0.72	0.70	0.72	0.47	0.12	0.23	0.23
DII %	0.10	0.13	0.13	0.13	0.13	0.14	0.12	0.12	0.08	0.00
Public %	22.49	23.78	23.69	23.12	23.14	22.64	25.29	25.18	24.88	24.74

PEER COMPARISON FOR GUFIC BIOSCIENCES LIMITED

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR GUFIC BIOSCIENCES

Exchange Date	Purpose	Book Closure Dates
BSE 04-Sep-2024	Book Closure - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	19-Sep-2024 25-Sep-2024
BSE 04-Sep-2024	AGM - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	25-Sep-2024 25-Sep-2024
BSE 08-Aug-2024	Board Meeting - Quarterly Results	14-Aug-2024
BSE 29-May-2024	Dividend - Rs.0.1000 per share(10%)Final Dividend
BSE 23-May-2024	Board Meeting - Final Dividend & Audited Results	29-May-2024
BSE 07-Feb-2024	Board Meeting - Quarterly Results	14-Feb-2024
BSE 02-Nov-2023	Board Meeting - Quarterly Results	09-Nov-2023
BSE 13-Sep-2023	Book Closure - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	22-Sep-2023 29-Sep-2023
BSE 13-Sep-2023	AGM - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	29-Sep-2023 29-Sep-2023
BSE 29-Aug-2023	Board Meeting - Preferential Issue of shares	01-Sep-2023
BSE 04-Aug-2023	Board Meeting - Employees Stock Option Plan & Quarterly Results	11-Aug-2023
BSE 29-May-2023	Dividend - Rs.0.1000 per share(10%)Final Dividend
BSE 23-May-2023	Board Meeting - Final Dividend & Audited Results	29-May-2023
BSE 02-Feb-2023	Board Meeting - Quarterly Results	10-Feb-2023
BSE 03-Nov-2022	Board Meeting - Quarterly Results	11-Nov-2022
BSE 11-Aug-2022	Book Closure - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	26-Aug-2022 02-Sep-2022
BSE 11-Aug-2022	AGM - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	02-Sep-2022 02-Sep-2022
BSE 04-Aug-2022	Board Meeting - Quarterly Results	11-Aug-2022
BSE 20-May-2022	Dividend - Rs.0.1000 per share(10%)Final Dividend
BSE 13-May-2022	Board Meeting - Final Dividend & Audited Results	20-May-2022
BSE 02-Feb-2022	Board Meeting - Quarterly Results	09-Feb-2022
BSE 27-Oct-2021	Board Meeting - Quarterly Results	03-Nov-2021
BSE 30-Aug-2021	AGM - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	20-Sep-2021 20-Sep-2021
BSE 30-Aug-2021	Book Closure - Rs.0.1000 per share(10%)Final Dividend & A.G.M.	14-Sep-2021 20-Sep-2021

CORPORATE ANNOUNCEMENTS FOR GUFIC BIOSCIENCES

Exchange Date	Category File	Description
BSE 17-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for issue of duplicate share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith
BSE 08-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2024 is attached herewith.
BSE 04-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for loss of share certificate is attached herewith.
BSE 27-Sep-2024	Intimation FILE	Closure of Trading Window Intimation of closure of Trading Window is attached herewith.
BSE 25-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Voting Results and Consolidated Scrutinizer Report of 40th Annual General Meeting is attached herewith
BSE 25-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of AGM Proceedings of the 40th Annual General Meeting of the Company held on Wednesday September 25 2024 is attached herewith.
BSE 25-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Intimation of completion of second term of Mr. Shreyas Patel (DIN: 01638788) Independent Director of the Company is attached herewith.
BSE 25-Sep-2024	Outcome FILE	Board Meeting Outcome for Meeting Held On Wednesday September 25 2024 Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e. September 25 2024 inter-alia considered the matters attached herewith.
BSE 16-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for issue of duplicate share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith.
BSE 01-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement - Notice of 40th Annual General Meeting of the Company and e-voting details is attached herewith
BSE 31-Aug-2024	General Announcements FILE	Business Responsibility and Sustainability Reporting (BRSR) Business Responsibility and Sustainability Report for the Financial Year ended March 31 2024 is attached herewith
BSE 31-Aug-2024	General Announcements FILE	Reg. 34 (1) Annual Report. Annual Report for the Financial Year 2023-2024 along with the Notice of 40th Annual General Meeting is attached herewith.
BSE 31-Aug-2024	Intimation FILE	Intimation Of Record Date For Final Dividend & 40Th Annual General Meeting Intimation for book closure and record date for the purpose of 40th Annual General Meeting and payment of final dividend for the financial year ended March 31 2024.
BSE 31-Aug-2024	Intimation FILE	Shareholders Meeting - 40Th Annual General Meeting Of The Company Scheduled To Be Held On Wednesday September 25 2024 Intimation of 40th Annual General Meeting is attached herewith.
BSE 28-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement - Information regarding 40th Annual General Meeting of the Company is attached herewith
BSE 22-Aug-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith.
BSE 20-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Earnings Call Transcript Written Transcript of Earnings Conference Call held on August 14 2024 at 5:30 p.m. is attached herewith.
BSE 15-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement of extract of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2024 is attached herewith
BSE 14-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Audio Recording of the Earnings Conference Call held on August 14 2024 at 05:30 p.m. has been uploaded on the Companys website and can be accessed through the link: http://gufic.com/Notice/AudioRecording_140824.mp3.Written transcript of the same will be submitted in due course.
BSE 14-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for loss of share certificate is attached herewith.
BSE 14-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation on Unaudited Financial Results of the Company for the quarter ended June 30 2024 is attached herewith.
BSE 14-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the Board of Directors of the Company at its meeting held on 14.08.2024 has inter alia considered and approved the matters attached herewith.
BSE 14-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Director Intimation of Resignation of Dr. Balram Singh Non-Executive Non-Independent Director with effect from the close of business hours on 14.08.2024 is attached herewith.
BSE 14-Aug-2024	Outcome FILE	Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2024 Unaudited Financial Results (Standalone and Consolidated) along with Limited Review Report for the quarter ended June 30 2024 is attached herewith.
BSE 14-Aug-2024	Outcome FILE	Board Meeting Outcome for Meeting Held On Wednesday August 14 2024 Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e. August 14 2024 has inter-alia considered and approved the matters attached herewith.
BSE 09-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Wednesday August 14 2024 at 05:30 p.m. (IST) during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite which is attached herewith.
BSE 08-Aug-2024	Intimation FILE	Board Meeting Intimation for Consideration And Approval Of Inter Alia Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2024 GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results (Standalone And Consolidated) of the Company for the Quarter ended June 30 2024
BSE 06-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the details of meeting with the Analyst/ Institutional Investor.
BSE 01-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Credit Rating Intimation of Revision (upgradation) in Credit Rating is attached herewith
BSE 01-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for Issue of Duplicate cum IEPF Share Certificate in lieu of the lost share certificate is attached herewith

INSIDER TRADING FOR GUFIC BIOSCIENCES

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 02-Jun-2022 02-Jun-2022	Sell Market	450,000 @ 0.00 (0.46 %)	JAYESH CHOKSI
BSE 02-Jun-2022 02-Jun-2022	Sell Market	18,000 @ 0.00 (0.02 %)	JAYESH CHOKSI

BULK BLOCK DEALS FOR GUFIC BIOSCIENCES LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
No Bulk Block details found

DIVIDEND BY GUFIC BIOSCIENCES LIMITED

Ex Dividend Date	Dividend Type	Dividend
17-Sep-2024	DIVIDEND	0.1
21-Sep-2023	DIVIDEND	0.1
24-Aug-2022	DIVIDEND	0.1
09-Sep-2021	DIVIDEND	0.1
03-Nov-2020	DIVIDEND	0.05

SPLIT / BONUS BY GUFIC BIOSCIENCES LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Gufic Biosciences Limited

Gufic Biosciences share price

CONSOLIDATED QUARTERLY RESULT FOR GUFIC BIOSCIENCES LIMITED

STANDALONE QUARTERLY RESULT FOR GUFIC BIOSCIENCES LIMITED

CONSOLIDATED ANNUAL RESULT FOR GUFIC BIOSCIENCES LIMITED

STANDALONE ANNUAL RESULT FOR GUFIC BIOSCIENCES LIMITED

CONSOLIDATED PROFIT / LOSS FOR GUFIC BIOSCIENCES LIMITED

STANDALONE PROFIT / LOSS FOR GUFIC BIOSCIENCES LIMITED

CONSOLIDATED CASH FLOW FOR GUFIC BIOSCIENCES LIMITED

STANDALONE CASH FLOW FOR GUFIC BIOSCIENCES LIMITED

CONSOLIDATED BALANCE SHEET FOR GUFIC BIOSCIENCES LIMITED

STANDALONE BALANCE SHEET FOR GUFIC BIOSCIENCES LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR GUFIC BIOSCIENCES LIMITED

FINANCIAL RATIOS (STANDALONE) FOR GUFIC BIOSCIENCES LIMITED

SHARE HOLDING PATTERN FOR GUFIC BIOSCIENCES LIMITED

PEER COMPARISON FOR GUFIC BIOSCIENCES LIMITED

CORPORATE ACTIONS FOR GUFIC BIOSCIENCES

CORPORATE ANNOUNCEMENTS FOR GUFIC BIOSCIENCES

INSIDER TRADING FOR GUFIC BIOSCIENCES

BULK BLOCK DEALS FOR GUFIC BIOSCIENCES LIMITED

DIVIDEND BY GUFIC BIOSCIENCES LIMITED

SPLIT / BONUS BY GUFIC BIOSCIENCES LIMITED